Araim Pharmaceuticals Inc., of Tarrytown, N.Y., formed a long-term strategic partnership with Vault Bioventures to help advance its peptide library, which targets injuries and chronic diseases with unmet medical needs. The collaboration, triggered by positive findings from proof-of-concept studies in patient populations in two indications, is designed to leverage Araim's expertise in scientific discovery and research with Vault's capabilities in clinical and regulatory development and commercialization. Financial terms were not disclosed.